-
4
pages
-
English
-
Documents
-
2014
Description
Frost & Sullivan: Strong Pipeline ofFrost & Sullivan: Strong Pipeline of Monoclonal Antibodies (mAbs) Biosimilars in the US and Europe Lends Impetus to Global Market PR Newswire LONDON, Jan. 29, 2014 - The market is expected to soar from $1.
-
Publié par
-
Publié le
29 janvier 2014
-
Langue
English